Leveraging single-cell level multiplexed immunofluorescence (IF)
Characterizing the tumor microenvironment after IO biomarker targeting in clinical trials
What will be discussed?
- Gain insight as to how Multiplexed Immunofluorescence can be Utilized to Provide a Complete View of Tumor Behavior
- Track the Benefits of High-Order Multiplex Panels for Exploration of Immune Evasion Mechanisms
- Preview an Example of how MultiOmyx Analysis was Used to Characterize the Biological Effects of Dual PD-1 and CXCR4 Targeting in a Clinical Trial